GSK and Gilead Sciences received multiple approvals for pipeline products and benchmarked performance against competitors.

1 report, 1 independent Updated Sep 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

GSK Gilead Sciences FDA

Keep exploring

Part of

GSK and EXEL are developing treatments for PBC, and the FDA granted accelerated approval to Gilead Sciences for related therapies. All 1 developments

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28
Gilead Sciences
company in Madrid, Spain

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Sep 5fool.com